Filing Details
- Accession Number:
- 0001225208-22-006044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-22 17:19:44
- Reporting Period:
- 2022-04-21
- Accepted Time:
- 2022-04-22 17:19:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1494319 | Univar Solutions Inc. | UNVR | Wholesale-Chemicals & Allied Products (5160) | 261251958 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1644770 | David Jukes | C/O Univar Solutions Inc. 3075 Highland Parkway, Suite 200 Downers Grove IL 60515 | President, Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-21 | 28,290 | $21.75 | 277,671 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-04-21 | 21,710 | $22.94 | 299,381 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-21 | 50,000 | $32.23 | 249,381 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2022-04-21 | 28,290 | $21.75 | 28,290 | $21.75 |
| Common Stock | Stock Options (right to buy) | Disposition | 2022-04-21 | 21,710 | $22.94 | 21,710 | $22.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-02-06 | No | 4 | M | Direct | |
| 162,110 | 2030-02-21 | No | 4 | M | Direct |
Footnotes
- The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on March 3, 2022. A portion of the proceeds from these sales will be used to cover the Reporting Person's tax liability arising from the option exercise.
- All shares underlying this option have vested.
Billionaire Hedge Funds
